株式市場ニュース

TruistはFifth Third Bancorp (FITB)の目標株価を引き下げ、買い投資判断を維持

Truist Lowers PT on Fifth Third Bancorp (FITB), Keeps a Buy Rating

The panel's net takeaway is that Truist's price target cut for FITB reflects concerns about slowing loan growth, net interest …

JD.com（JD）とBYDが戦略的パートナーシップを締結

JD.com (JD) and BYD Enters a Strategic Partnership

The panel views JD.com's partnership with BYD as a strategic move that leverages JD's logistics footprint and BYD's EV and …

Morgan Stanley は Block (XYZ) に関して Buy レートを維持

Morgan Stanley Maintains a Buy on Block (XYZ)

The panel is largely bearish on Block (SQ), citing risks such as potential loss of institutional memory from significant headcount …

$2,000の医薬品キャップは、メディケアの退職者が年間1,500ドル以上を節約しています

The $2,000 Drug Cap Is Saving Medicare Retirees Over $1,500 a Year Right Now

The $2,000 Part D cap provides significant relief for high-cost drug users but may have unintended consequences. While it increases …

Huntington Bancshares (HBAN) RBC 2026 カンファレンスで発表、知っておくべきこと

Huntington Bancshares (HBAN) Presents at RBC 2026 Conference, Here’s What You Should Know

The panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, …

Stellantis (STLA) 考慮中国自動車メーカーとの提携

Stellantis (STLA) Considering Partnerships With Chinese Automakers

The panel consensus is that Stellantis' exploration of partnerships with Chinese OEMs is a desperate move to address its European …

米国株式は最悪の水準からやや回復したが、依然として下落して終了

U.S. Stocks Climb Well Off Worst Levels But Still Close Lower

The panelists agree that the market's resilience despite geopolitical tensions is deceptive, with energy infrastructure damage posing a significant risk …

バクスターの株価パフォーマンスは、他の医療機器株と比べてどうでしょうか？

How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?

The panel consensus is bearish on Baxter (BAX), citing persistent margin pressure, operational struggles, and a high debt load. While …

G2 Investment Partners は Xometry に関して新規ポジションを開始

G2 Investment Partners Initiates a New Position in Xometry

Despite impressive revenue growth, XMTR's significant net losses and unclear path to profitability remain a concern, with varying opinions on …

SBSW は重要な移動平均線を下回る顕著なクロスを実現しました。

SBSW Makes Notable Cross Below Critical Moving Average

The panel consensus is bearish on Sibanye Stillwater (SBSW) due to its sensitivity to PGM prices, South African operational risks, …

BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO

The panel discusses BioMarin's VOXZOGO (vosoritide) data, with mixed views on its commercial potential. Bulls highlight label expansion to infants …

ギリシャの新防空計画は、ロッキード・マーティン社の株価を押し上げますか？

Will Greece's New Air Defense Plan Boost Lockheed Martin's Stock?

The panel generally agrees that the $36B Greece deal for Lockheed Martin (LMT) is geopolitically important but economically modest, with …